The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
Abstract
We investigated whether in utero exposure to the Gram(−) bacteriotoxin lipopolysaccharide (LPS) induces dopamine (DA) neuron loss in rats. The proinflammatory cytokine tumor necrosis factor α (TNF‐α) kills DA neurons and is elevated in the brains of patients with Parkinson's disease (PD). LPS is a potent inducer of TNF‐α, and both are increased in the chorioamniotic environment of women who have bacterial vaginosis (BV) during pregnancy, suggesting that BV might interfere with the normal development of fetal DA neurons. Gravid female rats were injected intraperitoneally with either LPS or normal saline at embryonic day 10.5 and their pups were killed at postnatal day 21. The brains of the pups were assessed for DA and TNF‐α levels and DA cell counts in the mesencephalon using tyrosine hydroxylase immunoreactive (THir) cells as a DA neuron marker. Prenatal LPS exposure significantly reduced striatal DA (29%) and increased DA activity (72%) as well as TNF‐α (101%). Stereological cell counts in the mesencephalon were also significantly reduced (27%) by prenatal LPS exposure. Prenatal exposure to LPS, as might occur in humans with BV, produces a significant loss of THir cells in rats that is still present 33 days following a single injection of LPS. Since this cell loss is well past the normal phase of DA neuron apoptosis that occurs in early postnatal life, rats so exposed may have a permanent loss of DA neurons, suggesting that prenatal infections may represent risk factors for PD. © 2001 Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Induction of dopaminergic neuron phenotype in the midbrain by sonic hedgehog protein
Wang, M. Z., Jin, P., Bumcrot, D. A., Marigo, V., Mcmahon, A. P., Wang, E. A., Woolf, T., & Pang, K. (1995) · Nature Medicine · doi:10.1038/nm1195-1184 · Cited by 158
CD14 and other recognition molecules for lipopolysaccharide: A review
Kielian, T. L., & Blecha, F. (1995) · Immunopharmacology · doi:10.1016/0162-3109(95)00003-c · Cited by 152
Research works printed but not linked: 63
- Nagatsu T, 2000, Changes in cytokines and neurotrophins in Parkinson's disease, J Neural Transm, 60, 277
- 10.1007/s007020050028 · DOI · Paper page
- 10.1523/JNEUROSCI.19-09-03440.1999 · DOI · Paper page
- 10.1046/j.1471-4159.1998.70041584.x · DOI · Paper page
- 10.1016/0006-8993(95)01189-7 · DOI · Paper page
- 10.1016/S0736-5748(97)00029-4 · DOI · Paper page
- 10.1111/j.1749-6632.1998.tb09556.x · DOI
- 10.1006/exnr.1998.6715 · DOI · Paper page
- 10.1002/jlb.64.1.25 · DOI · Paper page
- 10.1002/jlb.60.1.8 · DOI · Paper page
- Paul WE, 1998, Fundamental immunology
- 10.1016/S0002-9378(98)70442-9 · DOI
- Gilstrap LC, 1997, Infection in pregnancy
- 10.1097/00003081-199906000-00004 · DOI
- 10.1111/j.1469-8749.1997.tb07554.x · DOI
- 10.1016/0002-9378(89)90515-2 · DOI · Paper page
- 10.1016/0002-9378(93)90297-V · DOI
- Fox H, 1997, Pathology of the placenta
- 10.1677/joe.0.1550401 · DOI
- Hillier SL, 1993, The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection, Obstet Gynecol, 81, 941
- 10.1016/S0002-9378(99)70227-9 · DOI
- 10.1093/humrep/13.12.3560 · DOI
- 10.1016/S0002-9378(96)70221-1 · DOI
- 10.1016/0002-9378(95)90562-6 · DOI
- 10.1016/S0387-7604(88)80094-9 · doi:10.1016/s0387-7604(88)80094-9
- 10.1210/endo.136.4.7895681 · DOI
- Miller AJ, 1997, Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response, Am J Physiol, 272, R857
- Meszaros K, 1991, Glucose utilization by Kupffer cells, endothelial cells, and granulocytes in endotoxemic rat liver, Am J Physiol, 260, G7
- 10.1016/S0006-8993(98)00088-2 · doi:10.1016/s0006-8993(98)00088-2
- 10.1006/exnr.2001.7688 · DOI · Paper page
- 10.1007/s007020050014 · DOI
- Kordower JH, 1998, Neuropathology of fetal nigral grafts in patients with Parkinson's disease, Mov Disord, 13, 88
- 10.1046/j.1365-2990.1999.00202.x · DOI
- Cavalieri U, 1966, A new approach to the pathogenesis of osteoporosis, G Gerontol, 14, 1187
- 10.1002/(SICI)1096-9861(19990621)409:1<25::AID-CNE3>3.0.CO;2-E · DOI
- 10.1016/S0022-510X(97)00100-7 · DOI · Paper page
- 10.1002/cne.901990207 · DOI · Paper page
- 10.1073/pnas.95.7.4013 · DOI · Paper page
- 10.1111/j.1471-4159.1992.tb09766.x · DOI · Paper page
- 10.1001/archneur.1991.00530160025009 · doi:10.1001/archneur.1991.00530160025009
- 10.1016/S0165-3806(96)00173-3 · DOI · Paper page
- 10.1002/cne.903310302 · DOI · Paper page
- 10.1016/S0006-8993(00)01945-4 · doi:10.1016/s0006-8993(00)01945-4
- 10.1007/BF00229549 · DOI
- LingZD GayleDA LiptonJW CarveyPM.Prenatal lipopolysaccharide alters postnatal dopamine in the laboratory rat. In: Nabeshima P editor. Catecholamine research: from molecular insights to clinical medicine.2001. New York: Kluwer Academic–Plenum [in press]. · DOI
- Gayle DA, 2000, LPS‐induced dowregulation of tyrosine hydroxylase immunoreactivity in rat promary mesencephalic cultures: potential role of cytokine and apoptosis, Soc Neurosci, 262, 667.23
- 10.1016/S0892-0362(97)00143-8 · DOI
- 10.1016/0169-328X(92)90045-D · DOI
- 10.1016/S0891-5849(98)00293-7 · DOI · Paper page
- 10.1002/biof.5520100210 · DOI
- 10.1002/syn.890180105 · DOI
- 10.1016/0140-6736(91)92989-F · DOI · Paper page
- Jenner P, 1996, Oxidative stress in Parkinson's disease and other neurodegenerative disorders, Pathol Biol (Paris), 44, 57
- 10.1016/S0166-4328(01)00168-1 · DOI
- 10.1016/1055-8330(95)90015-2 · DOI · Paper page
- 10.1007/BF02251479 · DOI
- 10.1523/JNEUROSCI.20-24-09207.2000 · DOI · Paper page
- 10.1002/(SICI)1520-6661(199907/08)8:4<155::AID-MFM3>3.0.CO;2-2 · doi:10.1002/(sici)1520-6661(199907/08)8:4<155::aid-mfm3>3.0.co;2-2
- 10.1016/S0002-9378(99)70301-7 · DOI
- 10.1016/S0140-6736(83)90802-4 · DOI · Paper page
- 10.1136/jnnp.51.6.753 · DOI
- 10.1212/WNL.53.3.566 · DOI
- 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O · DOI · Paper page
Cited by
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Self-citationSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144
Self-citationMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Self-citationGut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra-Rojas, I., Martínez-Hernández, N. E., Márquez-Sandoval, Y. F., Illades-Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,196
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Self-citationMicroglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
“in vitro causing the progressive and cumulative loss of DA neurons with time.(129,169,170) Although traditionally”
BackgroundTansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
The role of inflammation in perinatal brain injury
Hagberg, H., Mallard, C., Ferriero, D. M., Vannucci, S. J., Levison, S. W., Vexler, Z. S., & Gressens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.13 · Cited by 829
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Self-citationInflammation as a causative factor in the aetiology of Parkinson's disease
Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 624
Boksa, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.03.005 · Cited by 603
Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 583
Hagberg, H., Gressens, P., & Mallard, C. (2012) · Annals of Neurology · doi:10.1002/ana.22620 · Cited by 514
Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease
Lee Mosley, R., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K., Laurie, C., & Gendelman, H. E. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.006 · Cited by 387
Levesque, S., Taetzsch, T., Lull, M. E., Kodavanti, U., Stadler, K., Wagner, A., Johnson, J. A., Duke, L., Kodavanti, P., Surace, M. J., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002986 · Cited by 371
Developmental Neuropathology of Environmental Agents
Costa, L. G., Aschner, M., Vitalone, A., Syversen, T., & Soldin, O. P. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121424 · Cited by 364
Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation
Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363
Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 361
Chronic microglial activation and progressive dopaminergic neurotoxicity
Block, M. L., & Hong, J.-S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351127 · Cited by 322
Self-citationCicchetti, F., Drouin-Ouellet, J., & Gross, R. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.005 · Cited by 311
Paraquat and Parkinson's disease
Berry, C., La Vecchia, C., & Nicotera, P. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.217 · Cited by 309
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 306
The influence of microglia on the pathogenesis of Parkinson's disease
Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296
Liu, B., Gao, H.-M., & Hong, J.-S. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6361 · Cited by 285
Self-citationWang, W., Nguyen, L. T. T., Burlak, C., Chegini, F., Guo, F., Chataway, T., Ju, S., Fisher, O. S., Miller, D. W., Datta, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610099113 · Cited by 270
Effect of inflammation on central nervous system development and vulnerability: review
Hagberg, H., & Mallard, C. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000162851.44897.8f · Cited by 261
Stolp, H. B., & Dziegielewska, K. M. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01005.x · Cited by 257
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235
Parkinson’s disease as a result of aging
Rodriguez, M., Rodriguez‐Sabate, C., Morales, I., Sanchez, A., & Sabate, M. (2015) · Aging Cell · doi:10.1111/acel.12312 · Cited by 214
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
Carvey, P. M., Zhao, C. H., Hendey, B., Lum, H., Trachtenberg, J., Desai, B. S., Snyder, J., Zhu, Y. G., & Ling, Z. D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04281.x · Cited by 218
Self-citationKirsten, T. B., Chaves‐Kirsten, G. P., Chaible, L. M., Silva, A. C., Martins, D. O., Britto, L. R. G., Dagli, M. L. Z., Torrão, A. S., Palermo‐Neto, J., & Bernardi, M. M. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23089 · Cited by 122
Pei, Z., Pang, H., Qian, L., Yang, S., Wang, T., Zhang, W., Wu, X., Dallas, S., Wilson, B., Reece, J. M., et al. (2007) · Glia · doi:10.1002/glia.20545 · Cited by 105
Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide
ZHU, Y., CARVEY, P., & LING, Z. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.12.013 · Cited by 85
Self-citationEndotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits
Liu, Y., Qin, L., Wilson, B., Wu, X., Qian, L., Granholm, A.-C., Crews, F. T., & Hong, J.-S. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.014 · Cited by 84
Self-citationNeuropoietic cytokines in normal brain development and neurodevelopmental disorders
Stolp, H. B. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.009 · Cited by 70
Miller, V. M., Zhu, Y., Bucher, C., McGinnis, W., Ryan, L. K., Siegel, A., & Zalcman, S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.002 · Cited by 36
Aspects of innate immunity and Parkinson's disease
Huang, Y., & Halliday, G. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00033 · Cited by 22
Metadata
- Authors
- Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J., & Carvey, P. M.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 17
- Issue
- 1
- Pages
- 116-124
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2147080256
- Cited by
- 241
- References
- 5
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.